Serology
Point of Care – HIV PoCT ONLY
Clinical material provided (Liquid Stabilised Whole blood – 0.4 mL) to assess the detection of HIV using Point of Care Assays
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
HIV PoCT Screening – Ag, HIV PoCT Screening – Ab, HIV PoCT Confirmatory, HIV PoCT Interpretation
Point of Care – Influenza A & B Antigen PoCT ONLY
Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.5 mL) to assess the detection of Influenza antigen using Point of Care Assays
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
Influenza A Antigen PoCT, Influenza B Antigen PoCT
Point of Care – RSV Antigen PoCT ONLY
Simulated clinical material provided (Liquid Inactivated viral culture lysate – 0.5 mL) to assess the detection of RSV antigen using Point of Care Assays
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
RSV Antigen PoCT ONLY
Retroviral – HIV serology (comprehensive)
Clinical material provided (Liquid Serum / Plasma – 1.0 mL) to assess the detection of HIV using serological markers
Frequency / Number of samples
6 surveys / 2 samples per survey
Tests
HIV Ag/Ab Combination Screen, HIV Ag/Ab Combination Supplementary, HIV Antibody ONLY Screening, HIV Antibody ONLY Supplementary, HIV-2 Antibody ONLY Supplementary, HIV Antigen ONLY, HIV Antigen ONLY Confirmatory, HIV 1/2 Antibody Confirmatory, HIV 1 Only Antibody Confirmatory, HIV 2 Only Antibody Confirmatory, HIV Interpretation
Retroviral – HTLV serology
Clinical material provided (Liquid Serum / Plasma – 0.6 mL) to assess the detection of HTLV using serological markers
Frequency / Number of samples
6 surveys / 2 samples per survey
Tests
HTLV Antibody Screening, HTLV Antibody Supplementary, HTLV Antibody Confirmatory
Specimen Free Program
Educational tool for staff, presenting case studies and scenarios that may be encountered in serological and molecular testing laboratories
Frequency / Number of samples
5 surveys / 1 case study per survey
Tests
Answers to questions regarding the scenarios presented
Vaccine Preventable – Bordetella pertussis serology
Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Bordetella pertussis using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Bordetella pertussis IgG, Bordetella pertussis IgM, Bordetella pertussis IgA, Bordetella pertussis Toxin & FHA IgG, Bordetella pertussis Toxin & FHA IgM, Bordetella pertussis Toxin & FHA IgA, Bordetella pertussis Toxin IgG, Bordetella pertussis Toxin IgM, Bordetella pertussis Toxin IgA, Bordetella pertussis Interpretation
Vaccine Preventable – Influenza A & B Antibody serology
Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Influenza A & Influenza B using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Influenza A IgG, Influenza A IgM, Influenza A IgA, Influenza A Total Antibody, Influenza A Interpretation, Influenza B IgG, Influenza B IgM, Influenza B IgA, Influenza B Total Antibody, Influenza B Interpretation
Vaccine Preventable – Measles serology
Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Measles using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Measles IgG, Measles IgM, Measles Total Antibody, Measles Interpretation, Measles Confirmatory
Vaccine Preventable – Mumps serology
Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Mumps using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Mumps IgG, Mumps IgM, Mumps Total Antibody, Mumps Interpretation
Vaccine Preventable – Q fever serology
Clinical material provided (Liquid Serum / Plasma – 0.4 mL) to assess the detection of Q Fever using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Q fever Total Antibody, Q fever Phase 1 IgA, Q fever Phase 1 IgG, Q fever Phase 1 IgM, Q fever Phase 1 Total Antibody, Q fever Phase 2 IgA, Q fever Phase 2 IgG IFA, Q Fever Phase 2 IgG EIA, Q fever Phase 2 IgM IFA, Q Fever Phase 2 IgM EIA, Q fever Phase 2 Total Antibody, Q fever Interpretation
Vaccine Preventable – Varicella zoster serology
Clinical material provided (Liquid Serum / Plasma – 0.35 mL)to assess the detection of Varicella zoster virus using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Varicella Zoster IgG, Varicella Zoster IgM, Varicella Zoster Total Antibody, VZ Interpretation
